Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): a randomised, open-label, phase 2 trial
Jiang's team to customize your IV therapy plan
Genetic modifications are not favourable, mostly because of formal limitations to genetically modified organisms (GMO) and often due to technological difficulties
Synopsis This study investigates the impact of excessive glutathione intake on breast cancer chemotherapy resistance, showing that higher intake is linked to increased recurrence rates and poor prognosis, emphasizing the need for standardized glutathione usage during treatment
While dissolution is difficult to test in experimental settings, we were still able to test if these supplements would properly disintegrate.25 Insider Tip: Unexpectedly, some tablets included food coloring, which leached into the experimental solution